A cell-free system has been developed in budding yeast that provides direct evidence that the Dsk2/Dph1, Rad23/Rhp23 and Rpn10/Pus1 multiubiquitin-binding proteins, long implicated in substrate recognition and presentation to the 26S proteasome, actually fulfil such a role.
the mutants were crossed with each other and the rpn10∆ ∆/pus1∆ ∆ strain to obtain double and triple mutants, however, these strains showed synthetic phenotypes, implying that they each had overlapping functions with the RPN10/pus1 + gene [9] [10] [11] [12] [13] [14] [15] . Further evidence that these proteins played a role in substrate recognition was revealed by the finding that in fission yeast the cyclin-dependent kinase (Cdk) inhibitor Rum1 (a known target of proteasome-mediated degradation), accumulated in the pus1∆ ∆rhp23∆ ∆ mutant strain [10] . This work led to a model in which these proteins act as substrate-binding proteins that transport ubiquitinylated substrates from the E3 ubiquitin ligases (which add the ubiquitin chains to proteasome substrates) on to the proteasome [16] (Figure 1) .
After these initial studies on the function of the shuttle proteins, it was realized that a cell-free system would be required to demonstrate that these multiubiquitin-binding proteins played a direct role in recognition and turnover of ubiquitinylated substrates. The first such cell-free system was developed by Raasi and Pickart [17] . Surprisingly, they showed that the Rad23 protein did not appear to stimulate degradation by the proteasome, as predicted by the shuttle hypothesis, but actually inhibited degradation.
In the new studies, Deshaies and co-workers [3] have now developed a different cell-free system that actually behaves in a manner predicted by the shuttle hypothesis. In this system, 26S proteasomes are affinity-purified from budding yeast using an epitopetagged version of the Pre1 20S subunit from wild-type, rpn10∆ ∆, dsk2∆ ∆ or rad23∆ ∆ strains. As a substrate they use a ubiquitinylated form of the Cdk inhibitor Sic1. Wild-type proteasomes degraded ubiquitinylated Sic1 efficiently while those prepared from the rpn10∆ ∆ and rad23∆ ∆ strains were defective in Sic1 turnover. By adding epoxomicin, an inhibitor of proteolysis by the 20S proteasome core particle, the authors could show that the rpn10∆ ∆ and rad23∆ ∆ 26S proteasomes were also defective in deubiquitination of the Sic1 substrate. Importantly, if recombinant Rpn10 protein was added to the rpn10∆ ∆ proteasomes, efficient degradation and deubiquitination of the Sic1 substrate was restored.
Interestingly, this rescue was dosage dependent. The addition of low levels of Rpn10 protein was sufficient to rescue activity and had little effect on the activity of wild-type proteasomes. However, a twofold molar excess of Rpn10 protein was enough to observe an inhibition of Sic1 degradation by the wild-type proteasomes, and a fourfold molar excess inhibited all activity. Mutational analysis showed that the UIM domain, required for multi-ubiquitin binding in Rpn10, played a critical role in ubiquitinylated Sic1 degradation. This important result demonstrates for the first time that the UIM domain of Rpn10 plays a direct role in protein degradation. The authors went on to show that recombinant Rad23 could rescue the deubiquitinating activity of rad23∆ ∆ proteasomes. This rescue was also concentration dependent. At low concentrations Rad23 protein restored deubiquitinating activity, while it inhibited at higher concentrations. A threefold molar excess of Rad23 protein was used in the earlier experiments of Raasi and Pickart [17] , so their observed inhibition of degradation is consistent with the findings of Verma et al. [3] .
The genetic studies in yeast predicted that Rpn10/Pus1 and Rad23/Rhp23 had overlapping functions. It is therefore gratifying that in the in vitro system Rpn10 protein rescued the deubiquitinating activity when added to Rad23-deficient proteasomes, meaning that Rpn10 and Rad23 proteins acted redundantly. Surprisingly, although Rad23 protein could rescue the deubiquitinating activity of the Rad23-deficient proteasomes, it was not able to rescue the deubiquitinating of the Rpn10-deficient proteasomes. Additional experiments demonstrated that rescue of the deubiquitinating activity of Rad23-and Rpn10-deficient proteasomes required both the proteasomeinteracting UBL domain and the multi-ubiquitin-binding UBA domain of Rad23. Again this is consistent with studies in yeast which showed that both domains have to be present to rescue the defects in rad23∆ ∆rpn10∆ ∆ and rhp23∆ ∆pus1∆ ∆ yeast strains [10, 13] . In addition these observations reveal another inconsistency with the earlier in vitro system in which the UBL domain of Rad23 did not appear to be required for activity [17] . Finally, further evidence that the budding yeast Rad23 and Rpn10 proteins acted as alternative multi-ubiquitin receptors for the 26S proteasome was provided by a recent study [4] , which demonstrated that the proteasome could bind ubiquitinylated substrates directly via Rad23 and/or Rpn10. However, substrate turnover was not investigated in this system.
As all the studies up to this point had been on the contribution of Rad23 and Rpn10 to the degradation of Sic1, it was important to assess if similar findings were also observed for other known ubiquitin-proteasome substrates. To test this, a number of different epitope-tagged physiological substrates of the ubiquitin-proteasome system were expressed in different mutant backgrounds. Interestingly, there appeared to be some specificity in that the substrate protein Cln2, a G1 cyclin, was not stabilized in the rpn10∆ ∆, dsk2∆ ∆, ddi1∆ ∆, ufd1-1, rad23∆ ∆, rad23∆ ∆dsk2∆ ∆, rpn10∆ ∆rad23∆ ∆ or rad23∆ ∆ddi1∆ ∆ mutant strains. In contrast, Far1, a G1 Cdk inhibitor, showed higher levels of accumulation in a rad23∆ ∆ than in a rpn10∆ ∆ strain, while the Cdc42 effector Gic2 and the mitotic cyclin Clb2 both behaved in a manner similar to the Sic1 protein.
In addition, the endoplasmic reticulum associated degradation (ERAD) substrate CPY* was not stabilized in the rpn10∆ ∆ and rad23∆ ∆ strains but only in a ufd1-1 strain. Ufd1, in complex with Npl4 and the ATPase Cdc48 had previously been implicated in the ERAD pathway and these results implied that neither Rad23 nor Rpn10 played any part in presentation of substrates from this pathway [18] . It was surprising therefore that Rad23 was identified to be a critical component of ERAD in a genome-wide screen carried out in S. cerevisiae [19] . Further work will be required to resolve this apparent paradox. From the results described above, however, the different multi-ubiquitin-binding proteins seem to have some specificity for different ubiquitin-proteasome substrates. One simple model that might be proposed to account for this specificity is that the shuttle proteins interact specifically with the different ubiquitin ligases that add the ubiquitin chain to the substrate proteins. This does not appear to be the case, however, as both Cln2 and Gic2 protein substrates are targeted by the SCF Grr1 ubiquitin ligase but are turned over differently in the different multi-ubiquitin receptor mutant strains.
In conclusion, the development of a cell-free extract that behaves in a manner predicted from the previous genetic data represents a significant step forward in the study of recognition and presentation of ubiquitinylated substrates to the 26S proteasome. The combination of this cell-free system with microbial genetics should provide powerful tools with which to investigate this important topic in more detail. 
